1.Bioavailability of antioxidant power in green tea

Benzie, IFF, Szeto,     More...

Benzie, IFF, Szeto, YT, Strain, JJ, Tomlinson, B     Less

ATHEROSCLEROSIS[0021-9150], Published 1998, Volume 136, Pages S35-S35

收錄情况： WOS

WOS核心合集引用: 0  2023影響因子:  4.9  发表年影響因子:  2.885 

2.Response to bezafibrate in combined hyperlipidaemia

Lan, W, Tomlinson, B     More...

Lan, W, Tomlinson, B, Chau, YM, Say, TK, Lee, KKC, Critchley, JAJH, Mak, TWL, Lam, CWK     Less

ATHEROSCLEROSIS[0021-9150], Published 1998, Volume 136, Pages S55-S55

收錄情况： WOS

WOS核心合集引用: 0  2023影響因子:  4.9  发表年影響因子:  2.885 

3.Combination treatment with fluvastatin and gemfibrozil in resistant hyperlipidaemia

Tomlinson, B, Wong,     More...

Tomlinson, B, Wong, SY, Lan, W, Critchley, JAJH, Mak, TWL, Lam, CWK, Woo, KS, Sanderson, JB     Less

ATHEROSCLEROSIS[0021-9150], Published 1998, Volume 136, Pages S56-S56

收錄情况： WOS

WOS核心合集引用: 1  2023影響因子:  4.9  发表年影響因子:  2.885 

4.Familial hypercholesterolaemia in Hong Kong

Tomlinson, B, Lan, W     More...

Tomlinson, B, Lan, W, Mak, YT, Chan, YS, Mak, TWL, Critchley, JAJH, Maserei, JRL, Pang, CP     Less

ATHEROSCLEROSIS[0021-9150], Published 1998, Volume 136, Pages S59-S59

收錄情况： WOS

WOS核心合集引用: 0  2023影響因子:  4.9  发表年影響因子:  2.885 

5.Investigation of mutations and polymorphisms in the lipoprotein lipase gene

Chan, YS, Tomlinson,     More...

Chan, YS, Tomlinson, B, Mak, YT, Mak, TWL, Pang, CP     Less

ATHEROSCLEROSIS[0021-9150], Published 1998, Volume 136, Pages S67-S67

收錄情况： WOS

WOS核心合集引用: 0  2023影響因子:  4.9  发表年影響因子:  2.885 

6.Lipid abnormalities and their treatment in patients with acute myocardial infarction in Hong Kong

Mok, PHK, Tomlinson,     More...

Mok, PHK, Tomlinson, B, Lan, W, Sanderson, JE, Woo, KS     Less

ATHEROSCLEROSIS[0021-9150], Published 1998, Volume 136, Pages S72-S72

收錄情况： WOS

WOS核心合集引用: 0  2023影響因子:  4.9  发表年影響因子:  2.885 

7.In vitro antioxidant activities of various types of Chinese tea

Szeto, YT, Benzie, I     More...

Szeto, YT, Benzie, IFF, Tomlinson, B     Less

ATHEROSCLEROSIS[0021-9150], Published 1998, Volume 136, Pages S77-S77

收錄情况： WOS

WOS核心合集引用: 1  2023影響因子:  4.9  发表年影響因子:  2.885 

8.Total antioxidant power of plasma: male-female and anticoagulant related differences

Chung, WY, Benzie, I     More...

Chung, WY, Benzie, IFF, Tomlinson, B     Less

ATHEROSCLEROSIS[0021-9150], Published 1998, Volume 136, Pages S78-S78

收錄情况： WOS

WOS核心合集引用: 0  2023影響因子:  4.9  发表年影響因子:  2.885 

9.Atorvastatin treatment-related changes to in vivo oxidant: Antioxidant balance as assessed by plasma allantoin and lipid standardised vitamin E levels

Benzie, IFF, Tomlins     More...

Benzie, IFF, Tomlinson, B, Chung, WY, Szeto, YT     Less

ATHEROSCLEROSIS[0021-9150], Published 1999, Volume 144, Pages 25-26

收錄情况： WOS

WOS核心合集引用: 1  2023影響因子:  4.9  发表年影響因子:  2.877 

10.Effects of atorvastatin on platelet aggregation in whole blood

Fan, B, Tomlinson, B     More...

Fan, B, Tomlinson, B, Critchley, JAJH     Less

ATHEROSCLEROSIS[0021-9150], Published 1999, Volume 144, Pages 35-35

收錄情况： WOS

WOS核心合集引用: 2  2023影響因子:  4.9  发表年影響因子:  2.877 

11.Associations of polymorphisms in the apolipoprotein A1/C3/A4/A5 gene cluster with familial combined hyperlipidaemia in Hong Kong Chinese

Liu, ZK, Hu, M, Baum     More...

Liu, ZK, Hu, M, Baum, L, Thomas, GN, Tomlinson, B     Less

ATHEROSCLEROSIS[0021-9150], Published 2010, Volume 208, Issue 2, Pages 427-432

收錄情况： WOS SCOPUS

WOS核心合集引用: 36  2023影響因子:  4.9  发表年影響因子:  4.086 

12.A polymorphism in transforming growth factor-beta 1 is associated with carotid plaques and increased carotid intima-media thickness in older Chinese men: The Guangzhou Biobank Cohort Study-Cardiovascular Disease Subcohort

Deng, HB, Jiang, CQ,     More...

Deng, HB, Jiang, CQ, Tomlinson, B, Liu, B, Lin, JM, Wong, KS, Cheung, BMY, Lam, TH, Thomas, GN     Less

ATHEROSCLEROSIS[0021-9150], Published 2011, Volume 214, Issue 2, Pages 391-396

收錄情况： WOS SCOPUS

WOS核心合集引用: 16  2023影響因子:  4.9  发表年影響因子:  3.794 

13.Effects of statin treatments and polymorphisms in UGT1A1 and SLCO1B1 on serum bilirubin levels in Chinese patients with hypercholesterolaemia

Hu, M, Tomlinson, B     More...

Hu, M, Tomlinson, B     Less

ATHEROSCLEROSIS[0021-9150], Published 2012, Volume 223, Issue 2, Pages 427-432

收錄情况： WOS SCOPUS

WOS核心合集引用: 14  2023影響因子:  4.9  发表年影響因子:  3.706 

14.DGAT1 AND DGAT2 POLYMORPHISMS HAD NO EFFECT ON THE LIPID RESPONSES TO NIACIN IN CHINESE PATIENTS WITH DYSLIPIDAEMIA

Hu, M, Yang, Y, Ng,     More...

Hu, M, Yang, Y, Ng, C, Lee, C, Lee, V, Tomlinson, B     Less

ATHEROSCLEROSIS[0021-9150], Published 2014, Volume 235, Issue 2, Pages E256-E256

收錄情况： WOS

WOS核心合集引用: 0  2023影響因子:  4.9  发表年影響因子:  3.994 

15.EFFECT OF NIACIN ON OXIDIZED LOW-DENSITY LIPOPROTEIN LEVELS IN CHINESE PATIENTS WITH DYSLIPIDAEMIA

Hu, M, Yang, Y, Yama     More...

Hu, M, Yang, Y, Yamashita, S, Masuda, D, Tomlinson, B     Less

ATHEROSCLEROSIS[0021-9150], Published 2014, Volume 235, Issue 2, Pages E256_E256

收錄情况： WOS

WOS核心合集引用: 1  2023影響因子:  4.9  发表年影響因子:  3.994 

16.IS THERE A ROLE FOR NIACIN IN FAMILIAL HYPERCHOLESTEROLAEMIA?

Hu, M, Yang, YL, Mas     More...

Hu, M, Yang, YL, Masuda, D, Yamashita, S, Tomlinson, B     Less

ATHEROSCLEROSIS[0021-9150], Published 2015, Volume 241, Issue 1, Pages E109-E109

收錄情况： WOS

WOS核心合集引用: 0  2023影響因子:  4.9  发表年影響因子:  3.942 

17.INFLUENCE OF FARNESOID X RECEPTOR AND BILE ACID TRANSPORTER POLYMORPHISMS ON THE PHARMACOKINETICS OF URSODEOXYCHOLIC ACID

Hu, M, Fok, B, Wo, S     More...

Hu, M, Fok, B, Wo, SK, Lee, V, Zuo, Z, Tomlinson, B     Less

ATHEROSCLEROSIS[0021-9150], Published 2015, Volume 241, Issue 1, Pages E118-E118

收錄情况： WOS

WOS核心合集引用: 0  2023影響因子:  4.9  发表年影響因子:  3.942 

18.GENETIC VARIANTS AND LIPID TRAITS IN THE HONG KONG CHINESE PATIENTS WITH TYPE 2 DIABETES

Hu, M, Tam, C, So, W     More...

Hu, M, Tam, C, So, WY, Chan, J, Tomlinson, B, Ma, R     Less

ATHEROSCLEROSIS[0021-9150], Published 2016, Volume 252, Pages E148-E148

收錄情况： WOS

WOS核心合集引用: 0  2023影響因子:  4.9  发表年影響因子:  4.239 

19.GENETIC, OMICS AND IN SILICO APPROACHES. RARE VARIANTS IN ABCG2 IDENTIFIED BY SEQUENCING MAY INFLUENCE THE LIPID RESPONSE TO ROSUVASTATIN TREATMENT

Hu, M, Chan, J, Toml     More...

Hu, M, Chan, J, Tomlinson, B     Less

ATHEROSCLEROSIS[0021-9150], Published 2016, Volume 252, Pages E202-E203

收錄情况： WOS

WOS核心合集引用: 0  2023影響因子:  4.9  发表年影響因子:  4.239 

20.SEVERE HYPERTRIGLYCERIDEAMIA RELATED TO A NOVEL MUTATION IN TRIB1 AND A KNOWN VARIANT IN APOA5

Tomlinson, B, Hu, M,     More...

Tomlinson, B, Hu, M, Chan, J, Mcintyre, A, Hegele, R     Less

ATHEROSCLEROSIS[0021-9150], Published 2017, Volume 263, Pages E230-E230

收錄情况： WOS

WOS核心合集引用: 0  2023影響因子:  4.9  发表年影響因子:  4.467